Sutro Biopharma, Inc.

STRO · NasdaqGM

$9.11+2.71%(+0.24)

Yahoo Finance · delay unknown · USD · 1 min old

Price history

Oct 28, 2025 · 11.10 USDOct 28, 2026 · 9.11 USD

Yahoo Finance · delay unknown · USD · 5 h old

Information, not investment advice.

Sutro Biopharma began a Phase 1 trial of its cancer drug STRO-006, with initial results expected in 2027.· summarised by Stockedin

Yahoo7 days agoalso at Benzinga2 reports mergedRead at the source

STRO

Finnhub · delay unknown · 7 days old

Headline and publisher summary only; full articles stay with the source.